Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: Prognostic but not therapeutic implications;Standpunt Nederlandse Melanoom Werkgroep inzake schildwachtklierprocedure: Wel prognostische betekenis, maar vooralsnog geen therapeutische consequenties

Nederlands Tijdschrift voor Geneeskunde

Volumn 152, Issue 10, 2008, Pages 574-576

  Kruit, W H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SIZE; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; HUMAN; INFORMED CONSENT; MELANOMA; MELANOMA CELL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SHORT SURVEY; SURVIVAL RATE; SURVIVAL TIME;

LYMPHATIC METASTASIS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 40849085487     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. Richtlijn Melanoom van de huid. Utrecht: Vereniging van Integrale Kankercentra en Kwaliteitsinstituut voor de Gezondheidszorg CBO; 2005.
2. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-17.
3. Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2007;18(Suppl): ii71-3.